Endo USA, Inc. recalls
Endo USA, Inc. is named on 5 recalls in Recall Relay's records since November 2023, from FDA (11 recalled products: FDA lists each product as its own recall); the most recent was March 13, 2026.
All 11 recalled products, newest first.
-
Class IIofficial
ENDO USA, Inc. recalls Buprenorphine HydrochlorideCrystallization; identified as Buprenorphine free base
-
Class IIIofficial
Endo USA, Inc. recalls Everolimus tablets 5mgFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class IIIofficial
Endo USA, Inc. recalls Everolimus tablets 10 mgFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class IIIofficial
Endo USA, Inc. recalls Everolimus tablets 2.5 mgFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class IIIofficial
Endo USA, Inc. recalls Everolimus tablets 7.5mgFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class IIIofficial
Endo USA, Inc. recalls Everolimus tablets 5mgFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class Iofficial
ENDO USA, Inc. recalls Adrenalin Chloride Solution (Epinephrine Nasal SolutionLabeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)
-
Class Iofficial
Endo USA, Inc. recalls Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
-
Class Iofficial
Endo USA, Inc. recalls Clonazepam Orally Disintegrating TabletLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
-
Class Iofficial
Endo USA, Inc. recalls Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
-
Class Iofficial
Endo USA, Inc. recalls Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Endo USA, Inc. or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts